Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,425 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decreased hospital stay and significant cost savings after routine use of prophylactic gastrostomy for high-risk patients with head and neck cancer receiving chemoradiotherapy at a tertiary cancer institution.
Hughes BG, Jain VK, Brown T, Spurgin AL, Hartnett G, Keller J, Tripcony L, Appleyard M, Hodge R. Hughes BG, et al. Among authors: keller j. Head Neck. 2013 Mar;35(3):436-42. doi: 10.1002/hed.22992. Epub 2012 May 18. Head Neck. 2013. PMID: 22605643
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study.
Poulsen MG, Denham JW, Peters LJ, Lamb DS, Spry NA, Hindley A, Krawitz H, Hamilton C, Keller J, Tripcony L, Walker Q. Poulsen MG, et al. Among authors: keller j. Radiother Oncol. 2001 Aug;60(2):113-22. doi: 10.1016/s0167-8140(01)00347-4. Radiother Oncol. 2001. PMID: 11439206 Clinical Trial.
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study.
Poulsen M, Rischin D, Walpole E, Harvey J, Macintosh J, Ainslie J, Hamilton C, Keller J, Tripcony L. Poulsen M, et al. Among authors: keller j. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):156-63. doi: 10.1016/s0360-3016(01)01577-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11516865 Clinical Trial.
High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07.
Poulsen M, Rischin D, Walpole E, Harvey J, Mackintosh J, Ainslie J, Hamilton C, Keller J, Tripcony L; Trans-Tasman Radiation Oncology Group. Poulsen M, et al. Among authors: keller j. J Clin Oncol. 2003 Dec 1;21(23):4371-6. doi: 10.1200/JCO.2003.03.154. J Clin Oncol. 2003. PMID: 14645427 Clinical Trial.
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK, Matthews JH, Turner SL, Mameghan H, Duchesne GM, Spry N, Berry MP, Keller J, Tripcony L; Trans Tasman Radiation Oncology Group. Gogna NK, et al. Among authors: keller j. Radiother Oncol. 2006 Oct;81(1):9-17. doi: 10.1016/j.radonc.2006.09.001. Epub 2006 Sep 28. Radiother Oncol. 2006. PMID: 17011058 Clinical Trial.
3,425 results